Literature DB >> 19218500

Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid.

Fang Wang1, Min Suk Kim, Prasanth Puthanveetil, Girish Kewalramani, Sylvia Deppe, Sanjoy Ghosh, Ashraf Abrahani, Brian Rodrigues.   

Abstract

Following diabetes, the heart increases its lipoprotein lipase (LPL) at the coronary lumen by transferring LPL from the cardiomyocyte to the endothelial lumen. We examined how hyperglycemia controls secretion of heparanase, the enzyme that cleaves myocyte heparan sulphate proteoglycan to initiate this movement. Diazoxide (DZ) was used to decrease serum insulin and generate hyperglycemia. A modified Langendorff technique was used to separate coronary from interstitial effluent, which were assayed for heparanase and LPL. Within 30 min of DZ, interstitial heparanase increased, an effect that closely mirrored an augmentation in interstitial LPL. Endothelial cells were incubated with palmitic acid (PA) or glucose, and heparanase secretion was determined. PA increased intracellular heparanase, with no effect on secretion of this enzyme. Unlike PA, glucose dose-dependently lowered endothelial intracellular heparanase, which was strongly associated with increased heparanase activity in the incubation medium. Preincubation with cytochalasin D or nocodazole prevented the high glucose-induced depletion of intracellular heparanase. Our data suggest that following hyperglycemia, translocation of LPL from the cardiomyocyte cell surface to the apical side of endothelial cells is dependent on the ability of the fatty acid to increase endothelial intracellular heparanase followed by rapid secretion of this enzyme by glucose, which requires an intact microtubule and actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218500     DOI: 10.1152/ajpheart.01312.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.

Authors:  Anthony J Monteforte; Brian Lam; Subhamoy Das; Somshuvra Mukhopadhyay; Catherine S Wright; Patricia E Martin; Andrew K Dunn; Aaron B Baker
Journal:  Biomaterials       Date:  2016-04-11       Impact factor: 12.479

2.  Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches.

Authors:  Moshe Lapidot; Uri Barash; Yaniv Zohar; Yuval Geffen; Inna Naroditsky; Neta Ilan; Lael Anson Best; Israel Vlodavsky
Journal:  J Clin Cell Immunol       Date:  2015-02

3.  Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics.

Authors:  Jeffrey M Mattson; Raphaël Turcotte; Yanhang Zhang
Journal:  Biomech Model Mechanobiol       Date:  2016-08-04

4.  Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease.

Authors:  Ahmet Seyfeddin Gurbuz; Semi Ozturk; Suleyman Cagan Efe; Mehmet Fatih Yilmaz; Raziye Ecem Yanik; Ali Yaman; Cevat Kirma
Journal:  Med Princ Pract       Date:  2019-09-04       Impact factor: 1.927

5.  Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.

Authors:  G Rao; H G Ding; W Huang; D Le; J B Maxhimer; A Oosterhof; T van Kuppevelt; H Lum; E J Lewis; V Reddy; R A Prinz; X Xu
Journal:  Diabetologia       Date:  2011-03-20       Impact factor: 10.122

Review 6.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

Review 7.  Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.

Authors:  Andrea Wan; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-06-10       Impact factor: 10.787

8.  Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels.

Authors:  Itay Shafat; Neta Ilan; Samih Zoabi; Israel Vlodavsky; Farid Nakhoul
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

Review 9.  Endothelial cell-cardiomyocyte crosstalk in heart development and disease.

Authors:  Andrea Colliva; Luca Braga; Mauro Giacca; Serena Zacchigna
Journal:  J Physiol       Date:  2019-03-27       Impact factor: 5.182

10.  Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation.

Authors:  Min Suk Kim; Fang Wang; Prasanth Puthanveetil; Girish Kewalramani; Sheila Innis; Lucy Marzban; Susan F Steinberg; Travis D Webber; Timothy J Kieffer; Ashraf Abrahani; Brian Rodrigues
Journal:  Diabetes       Date:  2009-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.